Infosys Limited has informed the Exchange regarding 'Disclosure Under Regulation 30 Of SEBI LODR Regulations'.
INFY · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Infosys informed the exchanges that BASE Life Sciences A/S, a step-down wholly owned subsidiary, transferred its entire shareholding in BASE Life Sciences Inc. (also a step-down wholly owned subsidiary) to Infosys BPM UK Limited, another step-down wholly owned subsidiary, effective May 1, 2025. As a result, Infosys BPM UK Limited now holds 100% of BASE Life Sciences Inc. The company stated the transfer is an internal inter-group restructuring aimed at enhancing operational efficiency, expanding market presence, and streamlining business operations. There is no change in ultimate ownership, as all entities involved remain wholly owned subsidiaries of Infosys. No benefit or impact on the promoter group was disclosed as it is marked 'Not Applicable'.
This is a routine internal restructuring among wholly owned subsidiaries with no change in ultimate ownership or shareholding pattern at the Infosys Limited level. Shareholders are unlikely to see any material impact on the stock price or business operations.